Abstract:Abstract Background Uterus corpus endometrial cancer (UCEC) is the main malignant tumor in gynecology, with a high degree of heterogeneity, especially in terms of prognosis and immunotherapy efficacy. DNA methylation is one of the most important epigenetic modifications. Studying DNA methylation can help predict the prognosis of cancer patients and provide help for clinical treatment. Our research aims to discover whether abnormal DNA methylation can predict the prognosis of UCEC and reflect the patient's tumor immune microenvironment. Patients and methods The clinical data, DNA methylation data, gene expression data and somatic mutation data of UCEC patients were all downloaded from the TCGA database. The MethylMix algorithm was used to integrate DNA methylation data and mRNA expression data. Univariate Cox regression analysis, Multivariate Cox regression analysis, and Lasso Cox regression analysis were used to determine prognostic DNA methylation-driven genes and to construct an independent prognostic index (MDS). ROC curve analysis and Kaplan–Meier survival curve analysis were used to evaluate the predictive ability of MDS. GSEA analysis was used to explore possible mechanisms that contribute to the heterogeneity of the prognosis of UCEC patients. Results 3 differential methylation-driven genes (DMDGs) (PARVG, SYNE4 and CDO1) were considered as predictors of poor prognosis in UCEC. An independent prognostic index was finally established based on 3 DMDGs. From the results of ROC curve analysis and survival curve analysis, MDS showed excellent prognostic ability in TCGA-UCEC. A new nomogram based on MDS and other prognostic clinical indicators has also been successfully established. The C-index of the nomogram for OS prediction was 0.764 (95% CI = 0.702–0.826). GSEA analysis suggests that there were differences in immune-related pathways among patients with different prognosis. The abundance of M2 macrophages and M0 macrophages were significantly enhanced in the high-risk group while T cells CD8, Eosinophils and Neutrophils were markedly elevated in the low-risk group. Meanwhile, patients in the low-risk group had higher levels of immunosuppressant expression, higher tumor mutational burden and immunophenoscore (IPS) scores. Joint survival analysis revealed that 7 methylation-driven genes could be independent prognostic factors for overall survival for UCEC. Conclusion We have successfully established a risk model based on 3 DMDGs, which could accurately predict the prognosis of patients with UCEC and reflect the tumor immune microenvironment.

Methylation-driven Genes and Their Prognostic Value in Cervical Squamous Cell Carcinoma.

The Methylation Modification of M6a Regulators Contributes to the Prognosis of Head and Neck Squamous Cell Carcinoma

Identification of EPHX2 and RMI2 As Two Novel Key Genes in Cervical Squamous Cell Carcinoma by an Integrated Bioinformatic Analysis

A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma

A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis

RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer

Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.

Novel Methylation-Driven Genes Identified As Prognostic Indicators for Lung Squamous Cell Carcinoma

Analysis of methylation-driven genes for predicting the prognosis of patients with oral squamous cell carcinoma

A 10-gene prognostic methylation signature for stage I–III cervical cancer

Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer

Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma

Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma

DNA methylation data–based molecular subtype classification related to the prognosis of patients with cervical cancer

Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic Ccrcc

Prognostic Value and Immune Infiltration of HPV Related Genes in the Immune Microenvironment of Cervical Cancer

Development of Potential Prognostic Biomarkers Based on DNA Methylation-Driven Genes for Patients with Endometrial Cancer.

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma

Methylation-related differentially expressed genes as potential prognostic biomarkers for cervical cancer

Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer

Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis